Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Estetra

Home Clinical Trial Sponsors and OrganizationsEstetra

Estetra

Rue Saint-Georges 5 7, Luik, Belgium

Also known as:

estetra sprl

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

15

0 active

Approvals

2

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

7

46.7%

Phase 3

5

33.3%

Phase 2

3

20.0%

Trial Status Distribution

Completed

15

100.0%

Clinical Trials

Trials sponsored by this organization (15)

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

Jan 202482 participants

Effect of Estetrol Monohydrate (E4) on QTc Interval

Mar 202132 participants

Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female Adolescents

Dec 2020145 participants

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

Dec 20191,570 participants

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)

Sep 20191,015 participants

Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) Study

Apr 201824 participants

E4/DRSP Ovarian Function Inhibition Study

Feb 201782 participants

Safety, Tolerability and Pharmacokinetics of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers

Jan 201731 participants

Page 1 of 2

Approvals

Approvals by Agency

EMA

European Medicines Agency

2

Approvals

Recent Approvals

News

No news articles found

On this page

Overview
Clinical Trials15
Approvals2
News

Back to Organizations